1. Home
  2. COLL vs AVAH Comparison

COLL vs AVAH Comparison

Compare COLL & AVAH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COLL
  • AVAH
  • Stock Information
  • Founded
  • COLL 2002
  • AVAH 1984
  • Country
  • COLL United States
  • AVAH United States
  • Employees
  • COLL N/A
  • AVAH N/A
  • Industry
  • COLL Biotechnology: Pharmaceutical Preparations
  • AVAH Hospital/Nursing Management
  • Sector
  • COLL Health Care
  • AVAH Health Care
  • Exchange
  • COLL Nasdaq
  • AVAH Nasdaq
  • Market Cap
  • COLL 1.1B
  • AVAH 1.1B
  • IPO Year
  • COLL 2015
  • AVAH 2021
  • Fundamental
  • Price
  • COLL $31.09
  • AVAH $4.80
  • Analyst Decision
  • COLL Strong Buy
  • AVAH Hold
  • Analyst Count
  • COLL 6
  • AVAH 3
  • Target Price
  • COLL $42.00
  • AVAH $4.27
  • AVG Volume (30 Days)
  • COLL 439.3K
  • AVAH 224.0K
  • Earning Date
  • COLL 11-07-2024
  • AVAH 11-07-2024
  • Dividend Yield
  • COLL N/A
  • AVAH N/A
  • EPS Growth
  • COLL 757.11
  • AVAH N/A
  • EPS
  • COLL 2.16
  • AVAH N/A
  • Revenue
  • COLL $599,245,000.00
  • AVAH $1,983,475,000.00
  • Revenue This Year
  • COLL $13.20
  • AVAH $7.90
  • Revenue Next Year
  • COLL $17.63
  • AVAH $5.04
  • P/E Ratio
  • COLL $14.32
  • AVAH N/A
  • Revenue Growth
  • COLL 9.62
  • AVAH 6.21
  • 52 Week Low
  • COLL $28.97
  • AVAH $2.00
  • 52 Week High
  • COLL $42.29
  • AVAH $6.19
  • Technical
  • Relative Strength Index (RSI)
  • COLL 48.70
  • AVAH 33.41
  • Support Level
  • COLL $29.67
  • AVAH $4.75
  • Resistance Level
  • COLL $31.10
  • AVAH $5.42
  • Average True Range (ATR)
  • COLL 0.98
  • AVAH 0.26
  • MACD
  • COLL 0.26
  • AVAH -0.10
  • Stochastic Oscillator
  • COLL 69.41
  • AVAH 3.75

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of highly abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.

About AVAH Aveanna Healthcare Holdings Inc.

Aveanna Healthcare Holdings Inc is a diversified home care platform that provides care to medically complex, high-cost patient populations. It directly addresses the pressing challenges facing the U.S. healthcare system by providing safe, high-quality care in the home. The firm provides its services through three segments: Private Duty Services (PDS); Home Health & Hospice (HHH); and Medical Solutions (MS). Private Duty Services include private duty nursing (PDN) and pediatric therapy services. Revenue is primarily derived from pediatric healthcare services provided to patients including private duty nursing and therapy services, adult home health and hospice services (collectively patient revenue) and from the delivery of enteral nutrition and other products to patients.

Share on Social Networks: